The nation of Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) over five years because of Washington's demand for confidential biological samples.
This move was revealed following a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa believed the deal was "unbalanced".
A government spokesperson has since stated that the United States was demanding access to health data for scientific study and commercial purposes while was not willing to share the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more talks to find a deal agreeable to all parties so the nation's vital HIV programme can be sustained.
Wider Context
This rejection follows a similar situation in Kenya, where a court blocked a related deal with the US following legal challenges were raised about the security of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had administered aid for the American government, but Trump stated its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and accountability.
According to statements, Sixteen African countries have to date agreed to these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Effectively, our nation would supply the raw materials for medical research with no assurance that the end products would be available to our citizens if a future pandemic arise."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks previously established via the international health agency.
Mangwana cited its Pandemic Benefit-Sharing framework created to deal with potential pandemics.
"This framework is intended to ensure that when a country provides its data, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome ongoing discussions with our US partners on how future collaboration could be arranged in a manner that honours the sovereignty and dignity of both nations."
Medical Community Response
A leading public health body expressed it understood the government's concerns, but urged that negotiations must proceed considering much of the nation's HIV programmes were funded by foreign aid.
"In cases where technical issues arise, including those involving information security or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," it added.
The situation emphasises the complex tensions between receiving crucial international aid and safeguarding a country's data in an increasingly interconnected world.